Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03929263 · ClinicalTrials.gov registry record · NA
Parent-Adolescent Training on Neurofeedback and Synchrony
A NA study of Testing Protocol With Healthy Individuals for Feasibility, sponsored by Oklahoma State University Center for Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03929263: Completed NA study of Testing Protocol With Healthy Individuals for Feasibility, sponsored by Oklahoma State University Center for Health Sciences.
NCT03929263 is a NA study of Testing Protocol With Healthy Individuals for Feasibility that has completed, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03929263, a NA study of Testing Protocol With Healthy Individuals for Feasibility, has completed, sponsored by Oklahoma State University Center for Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will test a real-time functional magnetic resonance imaging (fMRI) hyperscanning neurofeedback protocol for feasibility with ten mothers and their psychiatrically healthy adolescent daughters, with the eventual goal to test this in a sample of depressed adolescents in a future study.
Primary Outcome
Rating scale of perceived effectiveness in completing the task and changing brain activation. Likert scale ranging from 0-10, with higher numbers indicating greater perceived effectiveness.
Conditions Studied
Interventions
- BEHAVIORAL Real-time fMRI neurofeedback
Study Locations (1)
Oklahoma
- Laureate Institute for Brain Research - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-09-25 |
| Est. Completion | 2021-02-27 |
| Phase | NA |
What the finished NCT03929263 record still lists
NCT03929263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Testing Protocol With Healthy Individuals for Feasibility appearing as the primary indexed condition, and to 1 intervention - of which Real-time fMRI neurofeedback is the first listed.
NCT03929263 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT03929263 about?
NCT03929263 is a clinical study titled "Parent-Adolescent Training on Neurofeedback and Synchrony". The study will test a real-time functional magnetic resonance imaging (fMRI) hyperscanning neurofeedback protocol for feasibility with ten mothers and their psychiatrically healthy adolescent daughters, with the eventual goal to test this in a sample of depressed adolescents in a future study.
What is the current status of trial NCT03929263?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-09-25. Estimated completion is 2021-02-27.
What conditions does trial NCT03929263 study?
This clinical trial studies the following conditions: Testing Protocol With Healthy Individuals for Feasibility.
What interventions are being tested in trial NCT03929263?
The interventions under investigation include: Real-time fMRI neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03929263?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03929263 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03929263's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI